v3.26.1
Debt and Lines of Credit
 6 Months Ended
Jun. 30, 2026
Debt Disclosure [Abstract]  
Debt and Lines of Credit
Note 10 — Debt and Lines of Credit

In March 2026, Abbott issued $20.0 billion of debt to finance the acquisition of Exact Sciences, as follows:

(in millions)Principal amount
SOFR+ 50 bp Senior notes due 2029$1,000 
3.700% Senior notes due 2029
$2,250 
4.000% Senior notes due 2031
$2,500 
4.300% Senior notes due 2033
$2,750 
4.650% Senior notes due 2036
$3,750 
4.750% Senior notes due 2038
$2,000 
5.500% Senior notes due 2056
$3,750 
5.600% Senior notes due 2066
$2,000 
As part of the acquisition, Abbott assumed approximately $2.8 billion of Exact Sciences’ debt, nearly all of which was repaid as of June 30, 2026.
On September 15, 2025, Abbott repaid the $500 million outstanding principal amount of its 3.875% Notes upon maturity. On March 17, 2025, Abbott repaid the $1.0 billion outstanding principal amount of its 2.95% Notes upon maturity.